Rosen Comments on Implications of Delay on Passing FDARA

25 July 2017 Pink Sheet News

Partner David Rosen told Pink Sheet in an article, “FDA Gives Congress Reprieve on Deadline for Passing User Fee Bill,” that most Senators are still pushing to get the FDA Reauthorization Act done prior to October 1, 2017.

FDA Commissioner Gottlieb recently sent a memo to all FDA employees that it does not plan to send reduction in force notices on August 1, 2017 to employees that could lose their jobs if FDARA is not enacted by October 1, 2017. “Gottlieb would not be telling employees about his plans unless the agency was "comfortable that they have assurances that the bill is going to pass,” Rosen said.

(Subscription required to read)

Related Services

Insights